1004 Venture Partners empowers entrepreneurs with tools and invests in early-stage startup companies focused on healthy aging and transformative technologies in healthcare. The firm connects founders with its networks and provides mentorship.

1004 Venture Partners

1004 Venture Partners | 110 followers on LinkedIn. Healthy Aging Throughout Life | At 1004 Venture Partners, our mission is to transform the landscape of healthy aging investment. We specialize in identifying and nurturing cutting-edge, transformative technologies. Recognizing the challenges faced by entrepreneurs in early-stage startups, we are dedicated to providing the essential funding and resources needed for growth and success.

Our General Partner, Soyoung Park shared her thoughts about the future opportunities for the health data with the Big Tech industry at the LSI Europe 2024, at Sintra in Portugal.

Congrats to my partner Soyoung Park on her nomination as Female HealthTech Leader of the Year. She rocks.

We are proud that our General Partner, Soyoung Park , has been nominated for the Female HealthTech Leader of the Year award at the MedTech World Awards, which will be held at the Mediterranean Conference Centre in Malta on Friday, November 8th, 2024. We appreciate your support by voting for Soyoung for the MedTech Awards 2024! 🚨Voting is open until Monday, November 4th🎖️ https://lnkd.in/dyx5dWF5 #MedTechMalta24 #FemaleHealthTechLeaderoftheYear #MedTech #HealthTech #Leadetship

As an investor, you're often faced with a crucial decision: Do you bet on the jockey (the team) or the horse (the idea/market)? It's a question that's sparked countless debates in the venture capital world. Ideally, you want both a star team and a groundbreaking idea. But if pushed to choose, I lean towards the jockey. A great team can pivot a mediocre idea, but a weak team might fumble even the most promising opportunity. "What's your perspective? Are you Team Jockey or Team Horse? Share your thoughts below! 👇 #VentureCapital #StartupInvesting #EntrepreneurshipInsights

David H. Crean

https://lnkd.in/g7rQbMGT Interesting research posted this week in the journal Science on the use of Metformin, the most widely prescribed medication for diabetes, and its impact on aging.

Brilliant insights by Melanie Senior regarding the financing trends in Biotech. 1004 Venture Partners is expecting the waves of M&A in Biotech in 2025–2026 and encouraging prepared founders to get through the difficult time.

We are looking forward to the LSI Conference in September 2024 in which one of our General Partners Soyoung Park will be participating in a discussion centering on Agetech and the Global Aging Population.

Wonderful insights from reputable medtech leaders, including our own General Partner, Soyoung Park . https://lnkd.in/gzF66xpC #healthtech #medtech #innovation #FoundersvsMarkets

Time to increase the Healthspan against the extended Lifespan. #Logevity #Healthspan #HealthyAging

As a global fund, 1004 Venture Partners supports international entrepreneurs and looks forward to learning your transformative solutions. #interntionalfounders #USCISInterntionalEntrepreneurRule #GoGlobal

1004

COM:1004VENTUREPARTNERS

1004 Venture Partners

Filings Not Available